Cargando…

High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients

BACKGROUND: Considering the recent advancements in the treatment of breast cancer with low expression of human epidermal growth factor receptor 2 (HER2), we aimed to examine inter-laboratory variability in the assessment of HER2-low breast cancer across all Danish pathology departments. METHODS: Fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Kåre, Sode, Michael, Jensen, Maj-Britt, Berg, Tobias, Knoop, Ann, Ejlertsen, Bent, Lænkholm, Anne-Vibeke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636935/ https://www.ncbi.nlm.nih.gov/pubmed/37946261 http://dx.doi.org/10.1186/s13058-023-01739-9

Ejemplares similares

Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial
por: Skriver, Signe Korsgaard, et al.
Publicado: (2020)

The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients
por: Jensen, Maj-Britt, et al.
Publicado: (2020)

First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG
por: Celik, Alan, et al.
Publicado: (2022)

Danish Breast Cancer Cooperative Group
por: Christiansen, Peer, et al.
Publicado: (2016)

Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients
por: Christensen, Thomas, et al.
Publicado: (2020)

The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer
por: Jensen, Maj-Britt, et al.
Publicado: (2018)

Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial
por: Shenasa, Elahe, et al.
Publicado: (2022)

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study
por: Cold, Søren, et al.
Publicado: (2022)

The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study
por: Bens, Annet, et al.
Publicado: (2020)

The Impact of Diagnosis on Job Retention: A Danish Registry-Based Cohort Study
por: Espersen, Rasmus, et al.
Publicado: (2015)

Cartilage status in FAI patients – results from the Danish Hip Arthroscopy Registry (DHAR)
por: Lund, Bent, et al.
Publicado: (2017)

Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)
por: Berg, Tobias, et al.
Publicado: (2020)

Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
por: Kümler, Iben, et al.
Publicado: (2016)

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations
por: Steffensen, Ane Y., et al.
Publicado: (2010)

Danish Hip Arthroscopy Registry: an epidemiologic and perioperative description of the first 2000 procedures
por: Mygind-Klavsen, Bjarne, et al.
Publicado: (2016)

Danish Hip Arthroscopy Registry (DHAR): the outcome of patients with femoroacetabular impingement (FAI)
por: Lund, Bent, et al.
Publicado: (2017)

Danish Hip Arthroscopy Registry: Predictors of Outcome in Patients with Femoroacetabular Impingement (FAI)
por: Mygind-Klavsen, Bjarne, et al.
Publicado: (2016)

Danish Prostate Registry (DanProst) – an Updated Version of the Danish Prostate Cancer Registry, Methodology, and Early Results
por: Stroomberg, Hein Vincent, et al.
Publicado: (2023)

Hydatidiform mole: validity of the registration in the Danish National Patient Registry, the Danish Cancer Registry, and the Danish Pathology Registry 1999–2009
por: Lund, Helle, et al.
Publicado: (2018)

The Danish Nephrology Registry
por: Heaf, James
Publicado: (2016)

The Danish Stroke Registry
por: Johnsen, Søren Paaske, et al.
Publicado: (2016)

The Danish Schizophrenia Registry
por: Baandrup, Lone, et al.
Publicado: (2016)

The Danish Heart Registry
por: Özcan, Cengiz, et al.
Publicado: (2016)

Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
por: Rossing, Maria, et al.
Publicado: (2021)

Twin Studies in the Danish Cancer Registry, 1942-55
por: Nielsen, A., et al.
Publicado: (1957)

The Validity of Intracerebral Hemorrhage Diagnoses in the Danish Patient Registry and the Danish Stroke Registry
por: Hald, Stine Munk, et al.
Publicado: (2020)

Positive Predictive Value of Diagnostic Codes for Inflammatory Bowel Disease in the Danish National Patient Registry Among Individuals 50+ Years, Using Patient Records as Reference Standard
por: Rye, Camilla, et al.
Publicado: (2021)

The Danish National Acute Leukemia Registry
por: Østgård, Lene Sofie Granfeldt, et al.
Publicado: (2016)

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine
por: Stovgaard, Elisabeth S, et al.
Publicado: (2021)

Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of Patients
por: Wildenschild, Cathrine, et al.
Publicado: (2013)

The Danish Hip Arthroscopy Registry: Registration Completeness and Patient Characteristics Between Responders and Non-Responders
por: Poulsen, Erik, et al.
Publicado: (2020)

Large D-Dimer Fluctuation in Normal Pregnancy: A Longitudinal Cohort Study of 4,117 Samples from 714 Healthy Danish Women
por: Hedengran, Katrine K., et al.
Publicado: (2016)

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2014)

Twin Studies and Other Genetical Investigations in the Danish Cancer Registry
por: Busk, T., et al.
Publicado: (1948)

Danish cannabis policy revisited: Multiple framings of cannabis use in policy discourse
por: Søgaard, Thomas Friis, et al.
Publicado: (2021)

Statin use and risk of contralateral breast cancer: a nationwide cohort study
por: Langballe, Rikke, et al.
Publicado: (2018)

The Danish Adult Diabetes Registry
por: Jørgensen, Marit Eika, et al.
Publicado: (2016)

Danish Childhood Cancer Registry
por: Schrøder, Henrik, et al.
Publicado: (2016)

The Danish Vascular Registry, Karbase
por: Eldrup, Nikolaj, et al.
Publicado: (2016)

Danish National Lymphoma Registry
por: Arboe, Bente, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c4sjud3vokjfdtc69kptjef57f